Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Serum beta-cryptoxanthin

Table 2.6.a. Serum beta-cryptoxanthin: Total population

Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the total U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2001–2002.

Geometric mean
(95% conf. interval)

Selected percentiles (95% conf. interval)

Sample
|size

10th

50th

90th

Males and Females

Total, 3 years and older

7.51

(7.12-7.93)

3.20

(3.00-3.50)

7.50

(7.00-7.90)

17.8

(16.5-19.2)

8317

3–5 years

9.43

(8.40-10.6)

4.10

(3.30-5.50)

9.00

(7.80-10.5)

22.8

(18.3-27.8)

427

6–11 years

9.40

(8.71-10.2)

4.60

(4.10-5.10)

9.10

(8.20-10.1)

20.0

(17.0-22.9)

1006

12–19 years

7.63

(7.20-8.09)

3.70

(3.40-4.00)

7.50

(7.00-8.00)

15.8

(14.4-17.6)

2199

20–39 years

7.11

(6.57-7.69)

3.10

(2.80-3.50)

6.80

(6.30-7.50)

17.1

(15.2-19.3)

1707

40–59 years

7.28

(6.75-7.86)

3.00

(2.70-3.40)

7.10

(6.70-7.80)

17.4

(15.3-19.7)

1459

60 years and older

7.44

(6.84-8.09)

2.80

(2.50-3.20)

7.70

(7.00-8.30)

18.6

(17.5-19.6)

1519

Males

Total, 3 years and older

7.35

(6.96-7.77)

3.14

(2.80-3.40)

7.50

(6.90-7.90)

17.1

(16.0-18.5)

4032

3–5 years

9.80

(8.43-11.4)

4.20

(3.20-5.60)

9.60

(7.90-11.8)

22.8

(15.6-31.9)

217

6–11 years

9.63

(8.84-10.5)

5.00

(4.10-5.50)

9.30

(8.40-10.2)

21.2

(16.5-25.9)

503

12–19 years

7.64

(7.14-8.19)

3.70

(3.30-4.20)

7.50

(7.00-8.10)

15.5

(14.2-17.7)

1085

20–39 years

7.15

(6.49-7.88)

3.20

(2.80-3.50)

7.10

(6.10-8.00)

16.8

(15.2-19.8)

723

40–59 years

6.98

(6.57-7.42)

2.90

(2.50-3.30)

7.00

(6.50-7.60)

16.1

(14.6-18.5)

756

60 years and older

6.64

(6.02-7.31)

2.40

(1.90-2.90)

7.00

(6.00-7.60)

16.7

(15.8-17.7)

748

Females

Total, 3 years and older

7.67

(7.23-8.12)

3.40

(3.10-3.50)

7.50

(7.00-7.90)

18.2

(16.7-19.7)

4285

3–5 years

9.07

(7.79-10.6)

3.90

(3.00-5.30)

8.20

(6.40-10.4)

23.3

(17.3-32.1)

210

6–11 years

9.15

(8.21-10.2)

4.30

(4.00-4.80)

8.70

(7.80-10.7)

18.4

(16.1-21.6)

503

12–19 years

7.61

(7.10-8.16)

3.70

(3.40-4.00)

7.50

(7.00-8.00)

16.0

(14.3-17.5)

1114

20–39 years

7.07

(6.50-7.70)

3.10

(2.60-3.50)

6.70

(6.10-7.50)

17.5

(14.6-19.6)

984

40–59 years

7.61

(6.88-8.43)

3.10

(2.80-3.50)

7.30

(6.70-8.10)

18.5

(15.4-21.9)

703

60 years and older

8.10

(7.41-8.86)

3.10

(2.70-3.50)

8.20

(7.40-8.80)

20.1

(18.1-22.7)

771

 Top of Page

Table 2.6.b. Serum beta-cryptoxanthin: Mexican Americans

Geometric mean and selected percentiles of serum concentrations (in µg/dL) for Mexican Americans in the U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2001–2002.

Geometric mean
(95% conf. interval)

Selected percentiles (95% conf. interval)

Sample
size

10th

50th

90th

Males and Females

Total, 3 years and older

12.1

(11.1-13.1)

5.10

(4.80-5.70)

12.1

(10.8-13.5)

27.1

(25.0-29.8)

2114

3–5 years

11.0

(9.50-12.8)

5.20

(4.20-6.70)

10.3

(9.10-12.3)

23.6

(18.8-42.0)

126

6–11 years

11.9

(10.6-13.3)

6.20

(5.30-7.10)

11.1

(10.0-13.4)

24.1

(19.9-28.7)

290

12–19 years

9.72

(9.07-10.4)

4.80

(4.20-5.40)

9.70

(9.00-10.5)

19.8

(17.2-21.4)

696

20–39 years

13.4

(11.9-15.1)

5.60

(4.90-6.80)

14.0

(11.6-15.9)

30.0

(26.9-33.7)

460

40–59 years

12.2

(10.4-14.3)

4.70

(3.80-5.80)

12.7

(10.4-15.2)

27.3

(23.2-36.9)

287

60 years and older

11.0

(9.19-13.2)

3.70

(3.20-4.50)

11.1

(9.20-13.4)

28.5

(21.2-37.1)

255

Males

Total, 3 years and older

11.8

(10.7-13.1)

5.20

(4.70-5.70)

11.7

(10.4-13.4)

26.6

(23.8-29.9)

1018

3–5 years

11.1

(8.25-14.8)

5.50†

(3.60-6.90)

10.3

(6.80-15.9)

22.8†

(14.1-43.1)

62

6–11 years

11.6

(10.2-13.0)

5.60

(4.90-7.20)

10.9

(9.70-12.6)

24.1

(19.9-28.7)

140

12–19 years

9.32

(8.39-10.4)

4.70

(3.50-5.50)

9.34

(8.10-10.8)

18.5

(15.2-22.2)

330

20–39 years

12.9

(11.3-14.8)

5.30

(4.80-7.00)

13.4

(10.6-15.4)

29.8

(24.1-35.1)

213

40–59 years

12.9

(10.7-15.6)

5.10

(3.20-7.50)

13.1

(9.70-18.4)

28.7

(24.1-38.3)

147

60 years and older

9.87

(8.17-11.9)

3.50

(2.40-4.40)

10.8

(8.40-13.2)

23.9

(16.7-37.1)

126

Females

Total, 3 years and older

12.3

(11.4-13.3)

5.30

(4.90-6.00)

12.2

(10.9-13.9)

27.7

(25.3-32.1)

1096

3–5 years

11.0

(9.59-12.6)

4.70†

(3.20-7.50)

9.90

(7.70-12.7)

25.7†

(17.7-44.1)

64

6–11 years

12.2

(10.7-14.0)

6.80

(5.30-7.30)

11.4

(9.50-14.3)

25.4

(19.1-28.8)

150

12–19 years

10.2

(9.61-10.8)

5.10

(4.50-5.80)

10.0

(9.40-10.7)

20.8

(18.8-22.5)

366

20–39 years

13.9

(12.1-16.1)

6.00

(4.80-7.10)

14.6

(11.3-17.6)

32.2

(26.1-37.6)

247

40–59 years

11.5

(9.71-13.7)

4.50

(3.80-5.80)

11.9

(10.1-13.8)

26.5

(18.8-42.9)

140

60 years and older

12.0

(9.47-15.3)

4.30

(3.20-6.10)

11.7

(8.50-17.3)

29.7

(21.2-43.4)

129

† Estimate is subject to greater uncertainty due to small cell size.

 Top of Page

Table 2.6.c. Serum beta-cryptoxanthin: Non-Hispanic blacks

Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic blacks in the U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2001–2002.

Geometric mean
(95% conf. interval)

Selected percentiles (95% conf. interval)

Sample
size

10th

50th

90th

Males and Females

Total, 3 years and older

8.13

(7.50-8.81)

3.90

(3.40-4.20)

7.90

(7.40-8.50)

18.0

(15.7-20.7)

1987

3–5 years

10.9

(9.72-12.2)

5.80

(5.30-6.30)

10.2

(8.30-12.7)

20.9

(16.7-23.5)

128

6–11 years

12.0

(10.7-13.4)

6.50

(5.50-7.90)

11.8

(9.90-13.9)

23.0

(20.4-26.3)

338

12–19 years

8.94

(8.44-9.47)

4.70

(4.40-5.10)

8.80

(8.30-9.30)

16.6

(14.9-17.6)

670

20–39 years

7.60

(6.69-8.63)

4.00

(3.60-4.30)

7.00

(6.20-8.20)

15.4

(12.7-21.9)

318

40–59 years

6.79

(6.35-7.26)

3.10

(2.90-3.50)

6.60

(6.10-7.50)

15.5

(13.2-18.8)

290

60 years and older

7.89

(6.22-10.0)

3.00

(2.30-3.40)

7.80

(5.70-10.2)

20.5

(15.7-29.6)

243

Males

Total, 3 years and older

8.26

(7.59-8.99)

4.00

(3.50-4.30)

8.10

(7.30-9.10)

17.8

(15.7-20.4)

982

3–5 years

10.7

(9.29-12.3)

5.90†

(5.30-6.40)

10.2

(8.70-12.6)

20.1†

(16.1-22.7)

64

6–11 years

12.7

(11.2-14.4)

6.70

(5.60-8.30)

12.8

(10.9-14.2)

23.1

(18.6-30.9)

174

12–19 years

8.91

(8.29-9.58)

5.00

(4.50-5.40)

8.90

(8.20-9.30)

16.3

(14.4-18.8)

339

20–39 years

8.00

(6.63-9.67)

4.00

(2.80-5.00)

7.80

(5.70-10.2)

15.9

(13.9-21.9)

132

40–59 years

6.69

(6.09-7.34)

3.30

(2.90-3.70)

6.50

(5.80-7.30)

14.8

(12.1-19.1)

154

60 years and older

7.02

(5.69-8.66)

3.10

(2.20-3.50)

6.80

(5.70-8.20)

15.7

(9.30-27.1)

119

Females

Total, 3 years and older

8.02

(7.38-8.73)

3.70

(3.30-4.10)

7.80

(7.20-8.30)

18.0

(15.3-21.6)

1005

3–5 years

11.1

(9.30-13.2)

5.60†

(5.00-6.40)

10.6

(7.70-14.9)

20.9†

(15.4-53.1)

64

6–11 years

11.3

(9.47-13.4)

6.30

(4.40-7.70)

11.0

(8.50-13.8)

21.6

(14.7-28.4)

164

12–19 years

8.97

(8.48-9.49)

4.60

(4.00-5.00)

8.90

(8.60-9.80)

17.0

(15.2-17.7)

331

20–39 years

7.33

(6.38-8.42)

3.80

(3.40-4.30)

6.30

(6.10-7.30)

15.3

(10.8-24.6)

186

40–59 years

6.89

(6.31-7.52)

3.20

(2.50-3.70)

6.70

(5.90-7.80)

16.1

(12.9-19.1)

136

60 years and older

8.55

(6.37-11.5)

2.70

(2.30-4.10)

8.80

(5.10-13.9)

23.0

(16.5-34.7)

124

† Estimate is subject to greater uncertainty due to small cell size.

 Top of Page

Table 2.6.d. Serum beta-cryptoxanthin: Non-Hispanic whites

Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic whites in the U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2001–2002.

Geometric mean
(95% conf. interval)

Selected percentiles (95% conf. interval)

Sample
size

10th

50th

90th

Males and Females

Total, 3 years and older

6.84

(6.47-7.24)

3.00

(2.70-3.30)

6.80

(6.30-7.20)

15.6

(14.6-16.9)

3552

3–5 years

8.53

(7.14-10.2)

3.90

(2.80-5.50)

7.90

(6.40-10.4)

19.8

(14.4-31.9)

130

6–11 years

8.49

(7.67-9.38)

4.20

(3.80-4.90)

8.30

(7.40-9.10)

16.6

(14.6-21.8)

296

12–19 years

6.87

(6.41-7.36)

3.30

(2.80-3.80)

6.60

(6.10-7.00)

14.3

(12.5-16.6)

651

20–39 years

6.16

(5.63-6.73)

2.90

(2.60-3.40)

5.90

(5.40-6.50)

13.3

(11.1-16.4)

765

40–59 years

6.87

(6.39-7.38)

2.90

(2.70-3.30)

6.80

(6.20-7.40)

15.6

(13.9-18.0)

770

60 years and older

7.14

(6.56-7.76)

2.70

(2.30-3.20)

7.50

(6.70-8.10)

17.6

(16.4-19.1)

940

Males

Total, 3 years and older

6.64

(6.31-6.99)

2.90

(2.60-3.30)

6.50

(6.20-7.00)

14.7

(13.8-16.1)

1724

3–5 years

9.29

(7.45-11.6)

3.80†

(2.20-6.10)

8.90

(6.50-11.3)

23.9†

(12.1-56.4)

72

6–11 years

8.68

(7.70-9.77)

4.10

(3.70-5.10)

8.30

(7.40-9.20)

18.4

(13.8-26.3)

155

12–19 years

6.80

(6.30-7.33)

3.20

(2.80-3.60)

6.60

(6.10-7.40)

14.0

(11.8-16.6)

318

20–39 years

6.23

(5.54-7.01)

3.10

(2.70-3.50)

6.00

(5.40-6.70)

13.3

(10.8-16.5)

311

40–59 years

6.50

(6.17-6.84)

2.80

(2.35-3.30)

6.50

(5.90-7.10)

14.3

(12.5-16.0)

402

60 years and older

6.34

(5.77-6.96)

2.10

(1.90-2.60)

6.80

(5.70-7.60)

16.2

(15.2-17.2)

466

Females

Total, 3 years and older

7.04

(6.57-7.55)

3.10

(2.90-3.40)

6.80

(6.30-7.40)

16.4

(14.8-18.4)

1828

3–5 years

7.73

(5.91-10.1)

3.90†

(2.00-5.70)

7.10

(5.30-11.3)

15.0†

(11.7-33.0)

58

6–11 years

8.27

(6.92-9.87)

4.10

(3.50-4.90)

8.20

(6.40-10.9)

15.4

(13.5-18.7)

141

12–19 years

6.93

(6.33-7.59)

3.50

(3.00-4.00)

6.60

(6.00-7.10)

14.5

(12.7-16.9)

333

20–39 years

6.09

(5.54-6.70)

2.80

(2.40-3.40)

6.00

(5.40-6.60)

13.5

(10.8-17.8)

454

40–59 years

7.29

(6.52-8.16)

3.10

(2.90-3.70)

7.00

(6.10-7.90)

17.5

(13.5-22.2)

368

60 years and older

7.82

(7.06-8.66)

3.20

(2.70-3.60)

8.00

(7.30-8.60)

19.5

(16.9-21.6)

474

† Estimate is subject to greater uncertainty due to small cell size.

 Top of Page

  • Page last reviewed: July 30, 2008
  • Page last updated: July 30, 2008
  • Content source:
Top